Control of immune cell entry through the tumour vasculature: a missing link in optimising melanoma immunotherapy?

Metastatic melanoma remains a fatal disease to many worldwide, even after the breakthrough introduction of targeted therapies such as BRAF inhibitors and immune checkpoint blockade therapies such as CTLA-4 and PD-1 inhibitors. With advances in our understanding of this disease, as well as the increa...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Clin Transl Immunology
Asıl Yazarlar: Tan, Lih Yin, Martini, Carmela, Fridlender, Zvi G, Bonder, Claudine S, Brown, Michael P, Ebert, Lisa M
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Nature Publishing Group 2017
Konular:
Review
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5382436/
https://ncbi.nlm.nih.gov/pubmed/28435677
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cti.2017.7
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller